A prediction model ties emergency visits and opioid doses with return visits in children with sickle cell disease pain.
David Brousseau, MD, MS
Advertisement
David Brousseau is the pediatrician-in-chief, chair of pediatrics, and director of research at Nemours Children's Health.
Articles by David Brousseau, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
OMA 2026 Recap: GLP-1s in Conditions Beyond Obesity
3
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
4
Choosing Among Approved JAK Inhibitors: Baricitinib, Ritlecitinib, and Deuruxolitinib
5